Gr. Sarantis S.A.

Co. is a consumer goods manufacturer and distributor engaged in operations in Greece. Co. produces consumer goods such as cosmetics, pharmaceuticals, households, pet products, car's accessories and apparel. Co. produces its own brand name of cosmetic products such as Prosar, Str8, BU99, Clochard, Carroten, Tokalon and others. Co.'s product portfolio also includes a range of international brands such as Estee Lauder, Clinique, Aramis, Donna Karen, Orlane, Montana Versace and others.
  • TickerSAR
  • ISINGRS204003008
  • SectorPersonal Goods
  • CountryGreece

Analysts

Research Team

The Rear-View Mirror – EME markets: All markets down in December, highest loss in Romania

EME Equity Market – December 2018 Market performance – all markets down in December. The BET index reported the highest loss, of 14.7%, in December; while the MSCI EME was down 4.3%, vs. November’s 2.2% gain; the Turkish ISE recorded a loss of 6.2%, following the 13.3% mom rise in November; Prague’s PX index fell 6.8%, after November’s flat performance; Moscow’s index lost 5.9%, vs. the 0.5% loss in the previous month; Budapest’s BUX ended December with a loss of 1.7%; and Greece’s ASE lost 2.7%; while Warsaw’s WIG20 fell 0.9% (all performances measured in EUR terms).

Research Team

WOOD Morning (19 December)

HEADLINES: • Sarantis: From Greece with Love (stays BUY - transfer of coverage) • Romania macro: budget woes starting • Romanian banks: bank tax proposal NEGATIVE • Erste Bank/RBI: could be hit visibly by Romanian tax burden proposals NEGATIVE • OTE: potential impact of Romanian telecoms fee hike NEGATIVE • Romanian energy/telecoms/utilities: impact of the proposed fiscal measures on various sectors • Polish gencos: regulator delays the retail tariff hike, asks for more information NEGATIVE • ING BSK: aiming to buy a 45% stake in NN TFI NEUTRAL • Atrium: Fitch upgrades rating to BBB (from B...

Alex Boulougouris, CFA ...
  • Fani Tzioukalia

Sarantis: From Greece with Love (stays BUY - transfer of coverage)

In this report, we transfer coverage of Sarantis, retaining our BUY rating on the stock, with a new 12M price target (PT) of EUR 9.0/share (EUR 8.5 previously), offering 29.6% upside. We have updated our PT to reflect the changes in our estimates, based on our more conservative macro assumptions for the long term, while also adding our forecasts for 2021E. Despite the potential GDP slowdown in the region, we believe that growth is still evident through strategic acquisitions and the successful application of synergies. We therefore anticipate a solid EPS CAGR of 10.4% for the next four years, ...

1 director sold

A director at Sarantis Sa sold 40,000 shares at 7.372EUR and the significance rating of the trade was 73/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly showing Close periods where trading activity is restricted under listing rules. The names of board mem...

Research Team

The Rear-View Mirror – EME markets: Turkish equities stand out in November

EME Equity Market – November 2018 Market performance – Turkey up by 13.3% mom in EUR terms in November. The MSCI EME gained 2.2% in November, while the Turkish ISE rose by 13.3% in EUR terms, which was driven mostly by the appreciation of the TRY against EUR, as the index gained 6.1% mom in TRY terms. The Hungarian BUX was up by 8.3% mom, followed by the Polish WIG20 (+7.7% mom) and Romania’s BET (+1.8% mom). The Czech PX index was flat mom, while the Russian MOEX and the Greek ASE ended the month in negative territory (-0.3% mom and -1.5% mom, respectively).

Research Team

The Rear-View Mirror – EME markets: All markets down in December, highest loss in Romania

EME Equity Market – December 2018 Market performance – all markets down in December. The BET index reported the highest loss, of 14.7%, in December; while the MSCI EME was down 4.3%, vs. November’s 2.2% gain; the Turkish ISE recorded a loss of 6.2%, following the 13.3% mom rise in November; Prague’s PX index fell 6.8%, after November’s flat performance; Moscow’s index lost 5.9%, vs. the 0.5% loss in the previous month; Budapest’s BUX ended December with a loss of 1.7%; and Greece’s ASE lost 2.7%; while Warsaw’s WIG20 fell 0.9% (all performances measured in EUR terms).

Alex Boulougouris, CFA ...
  • Fani Tzioukalia

Sarantis: From Greece with Love (stays BUY - transfer of coverage)

In this report, we transfer coverage of Sarantis, retaining our BUY rating on the stock, with a new 12M price target (PT) of EUR 9.0/share (EUR 8.5 previously), offering 29.6% upside. We have updated our PT to reflect the changes in our estimates, based on our more conservative macro assumptions for the long term, while also adding our forecasts for 2021E. Despite the potential GDP slowdown in the region, we believe that growth is still evident through strategic acquisitions and the successful application of synergies. We therefore anticipate a solid EPS CAGR of 10.4% for the next four years, ...

Research Team

The Rear-View Mirror – EME markets: Turkish equities stand out in November

EME Equity Market – November 2018 Market performance – Turkey up by 13.3% mom in EUR terms in November. The MSCI EME gained 2.2% in November, while the Turkish ISE rose by 13.3% in EUR terms, which was driven mostly by the appreciation of the TRY against EUR, as the index gained 6.1% mom in TRY terms. The Hungarian BUX was up by 8.3% mom, followed by the Polish WIG20 (+7.7% mom) and Romania’s BET (+1.8% mom). The Czech PX index was flat mom, while the Russian MOEX and the Greek ASE ended the month in negative territory (-0.3% mom and -1.5% mom, respectively).

Natalia Svyrou-Svyriadi

SARANTIS - 9M18 results supportive of FY18 – Neutral at current levels

Natalia Svyrou-Svyriadi

SARANTIS - 9M:18 preview – Greece sentiment remains subdued, support from foreign countries and new acquisitions

1 director sold

A director at Sarantis Sa sold 40,000 shares at 7.372EUR and the significance rating of the trade was 73/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly showing Close periods where trading activity is restricted under listing rules. The names of board mem...

A director sold 5,000 shares at 12.997EUR and

A director at Sarantis Sa sold 5,000 shares at 12.997EUR and the significance rating of the trade was 55/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly showing Close periods where trading activity is restricted under listing rules. The names of boa...

Research Team

WOOD Morning (19 December)

HEADLINES: • Sarantis: From Greece with Love (stays BUY - transfer of coverage) • Romania macro: budget woes starting • Romanian banks: bank tax proposal NEGATIVE • Erste Bank/RBI: could be hit visibly by Romanian tax burden proposals NEGATIVE • OTE: potential impact of Romanian telecoms fee hike NEGATIVE • Romanian energy/telecoms/utilities: impact of the proposed fiscal measures on various sectors • Polish gencos: regulator delays the retail tariff hike, asks for more information NEGATIVE • ING BSK: aiming to buy a 45% stake in NN TFI NEUTRAL • Atrium: Fitch upgrades rating to BBB (from B...

Research Team

WOOD Morning (8 November)

HEADLINES: • Komercni Banka: very strong 3Q18, with strong quality mix POSITIVE • CEZ: 3Q18 in line, EBITDA guidance cut to CZK 50-51bn, but adjusted net profit raised by CZK 1bn NEGATIVE • Alior Bank: neutral set of 3Q18, but market may focus on growing NPLs NEUTRAL • Magyar Telekom: 3Q18 results - weak quarter, with 7% yoy EBITDA drop NEGATIVE • Migros: 3Q results beat, another guidance upgrade • Isbank: 3Q18 results review - weak core banking earnings, CHP stake struggle NEUTRAL • Tupras: 3Q18 quarter results - net income disappoints on FX • Aygaz: 3Q18 review - results in line, FY sale ...

Research Team

WOOD Morning (13 September)

HEADLINES: • OPAP: 2Q18 results - 5% beat on EBITDA on the back of tight cost control POSITIVE • Sarantis: 1H18 results - positive trends, remains a solid growth story POSITIVE • Richter: our first thoughts on the Estelle impact - not a game-changer • Echo Investment: a deep dive on why we remain bullish (plus a review of the key profit drivers for the next 18M) NEUTRAL • Medicalgorithmics: Apple Watch with heart monitoring and FDA clearance NEGATIVE • Enea: 2Q18 in line with preliminary numbers, boosted by windfarm impairment reversal NEUTRAL • Mytilineos: 1H18 - aluminium segment leading th...

Research Team

Focus: Echo Investment’s 2Q18 – headline results slightly better, but unit sales guidance cut again; Kruk – takeaways from the 2Q18 conference; Hellenic Bank’s 2Q18 results in line, but focus is on capital issue

HEADLINES: • Echo Investment: 2Q18 - headline results slightly better, but unit sales guidance cut again NEUTRAL • Kruk: takeaways from the 2Q18 conference POSITIVE • Hellenic Bank: 2Q18 results in line, but focus is on capital issue • Atrium: repurchases EUR 242m of existing bonds NEUTRAL • Medicalgorithmics: flat tests yoy in August NEGATIVE • Sarantis: 1H18E preview - reassuring results ahead (due out tomorrow, after the close) • Short News (CIE, GNB, OPL)

Research Team

WOOD Morning (13 June)

HEADLINES: * PKN Orlen: announces PLN 8.3bn petrochemicals investment * Warsaw Stock Exchange: supervisory board approves updated strategy - no details revealed NEUTRAL * CEZ: Zeman, Babis and Benes to meet on energy policy NEUTRAL * Cyfrowy Polsat: Sensor Overseas to sell up to 28.2m shares (a 4.4% stake) NEUTRAL * LPP: Inditex reports 1Q18 beat on gross margin - negative read-through for LPP NEGATIVE * Sarantis: stock split, ex-date today * Short News (GPW)

Ford Equity International Rating and Forecast Report

Ford Equity International Research Reports cover 60 countries with over 30,000 stocks traded on international exchanges. A proprietary quantitative system compares each company to its peers on proven measures of business value, growth characteristics, and investor behavior. Ford's three recommendation ratings buy, hold and sell, represent each stock’s return potential relative to its own country market.. The rating reports which are generated each week, include the fundamental details behind each recommendation and reflect the fundamental and price data as of the last trading day of the week...

MarketLine Department

Korres Natural Products SA - Strategy, SWOT and Corporate Finance Report

Summary Korres Natural Products SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company. Key Highlights Korres Natural Products SA (Korres) is a manufacturer and retailer of cosmetics and herbal products. The company’s product portfolio includes natural and organic skin and hair care products, make-up and herbal preparations. These products are marketed under KORRES brand. It offers...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch